• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Customer experience startup Clootrack raises $4M, helps brands see through their customers’ eyes

September 3, 2021 by David Barret Leave a Comment

Getting inside the mind of customers is a challenge as behaviors and demands shift, but Clootrack believes it has cracked the code in helping brands figure out how to do that.

It announced $4 million in Series A funding, led by Inventus Capital India, and included existing investors Unicorn India Ventures, IAN Fund and Salamander Excubator Angel Fund, as well as individual investment from Jiffy.ai CEO Babu Sivadasan. In total, the company raised $4.6 million, co-founder Shameel Abdulla told TechCrunch.

Clootrack is a real-time customer experience analytics platform that helps brands understand why customers stay or churn. Shameel Abdulla and Subbakrishna Rao, who both come from IT backgrounds, founded the company in 2017 after meeting years prior at Jiffstore, Abdulla’s second company that was acquired in 2015.

Clootrack team. Image Credits: Clootrack

Business-to-consumer and consumer brands often use customer satisfaction metrics like Net Promoter Score to understand the customer experience, but Abdulla said current methods don’t provide the “why” of those experiences and are slow, expensive and error-prone.

“The number of channels has increased, which means customers are talking to you, expressing their feedback and what they think in multiple places,” he added. “Word of mouth has gone digital, and you basically have to master the art of selling online.”

Clootrack turns the customer experience data from all of those first-party and third-party touchpoints — website feedback, chat bots, etc. — into granular, qualitative insights that give brands a look at drivers of the experience in hours rather than months so that they can stay on top of fast-moving trends.

Abdulla points to data that show a customer’s biggest driver of brand switch is the experience they receive. And, that if brands can reduce churns by 5%, they could be looking at an increase in profits of between 25% and 95%.

Most of the new funding will go to product development so that all data aggregations are gathered from all possible touchpoints. His ultimate goal is to be “the single platform for B2C firms.”

The company is currently working with over 150 customers in the areas of retail, direct-to-consumer, banking, automotive, travel and mobile app-based services. It is growing nine times year over year in revenue. It is mainly operating in India, but Clootrack is also onboarding companies in the U.S. and Europe.

Parag Dhol, managing director of Inventus, said he has known Abdulla for over five years. He had looked at one of Abdulla’s companies for investment, but had decided against it due to his firm being a Series A investor.

Dhol said market research needs an overhaul in India, where this type of technology is lagging behind the U.S.

“Clootrack has a very complementary team with Shameel being a complete CEO in terms of being a sales guy and serial entrepreneur who has learned his lessons, and Subbu, who is good at technology,” he added. “As CMOs realize the value in their unstructured data inside of their own database of the customer reviews and move to real-time feedback, these guys could make a serious dent in the space.”

Optimizing customer retention will be a priority in 2020

 

Source Link Customer experience startup Clootrack raises $4M, helps brands see through their customers’ eyes

David Barret
David Barret

Related posts:

  1. Airtel tests cloud gaming experience on 5G network
  2. JBL Quantum 350 looks like a great affordable wireless gaming headset
  3. Canada trade surplus narrowed in July to C$778 million
  4. Life insurers shift to pre-pandemic norms after COVID vaccine roll-outs

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Fresh From Capturing Image Of 3I/ATLAS, NASA’s MAVEN Suffers “Anomaly” And Is No Longer Communicating With Earth
  • Thought “Superflu” Was Bad? Strap In: It’s Norovirus Season In The US
  • Why Does Evolution Turn Everything Into Crabs?
  • Neil deGrasse Tyson And Professor Brian Cox Talk Interstellar Comet 3I/ATLAS And Alien Spacecraft: “It’s Older Than Us”
  • New Species Of Tiny Pumpkin Toadlet Is The Size Of A Pencil Tip, And We Cannot Cope
  • Watch The World’s Most Metal Frog Take Down A Giant “Murder Hornet”
  • Scheduling Cancer Immunotherapy In The Morning May Lower Your Risk Of Death By As Much As 63 Percent
  • Spacetime Vortices Spotted For The First Time As Black Hole Kills A Star
  • The Never-Before-Seen First Stars In The Universe May Have Finally Been Spotted
  • There’s Finally An Explanation For The Longest Known Gamma Ray Burst’s Appearance – But A Key Mystery Remains
  • The Earliest Evidence Of Making Fire Has Been Discovered, Dating To 400,000 Years Ago
  • First X-Ray Image Of Comet 3I/ATLAS Reveals Signature Unseen In Other Interstellar Objects
  • The Surprisingly Scientific Events That Occurred On Christmas Day
  • Humans Are The Smartest And Dumbest Animal Of All Time, Argues Biologist
  • The Final Secret Of Self-Healing Roman Concrete May Have Been Cracked
  • People Are Confused By The Natural Markings On Watermelons That Look Like “Crop Circles”
  • Pica: The Disorder That Makes People Crave And Eat The Inedible
  • Project Alpha: In 1979, Magicians Infiltrated A Washington Laboratory To Test Scientific Rigor In Parapsychology
  • We May Finally Know What Caused The “Hobbit” Humans To Go Extinct
  • Radical New Treatment Clears Disease In 64 Percent Of Patients With Incurable Cancer
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version